Charles River Laboratories International Aktie
147,15
EUR
+7,15
EUR
+5,11
%
170,02
USD
+2,37
USD
+1,41
%
Werbung
Charles River Laboratories International Aktie Analyse
| 06.09.16 | Charles River Laboratories International Sell | UBS AG | |
| 20.05.16 | Charles River Laboratories International Underweight | Barclays Capital | |
| 10.07.15 | Charles River Laboratories International Underweight | Barclays Capital |
Werbung
Werbung